During the 2024–2025 biennium, PAHO played a key role in transforming the care model of the Guatemalan Social Security Institute (IGSS, Spanish acronym) through the formulation and initial implementation of the Family and Community Health Strategy. Through sustained, sequential, and territorially focused technical cooperation, PAHO supported the design of a model of care based on primary health care (PHC) and integrated health services delivery networks, the definition of a service delivery portfolio oriented to the needs of individuals and families, and the strengthening of health workforce capacities through specialized training processes. In addition, PAHO supported the initial rollout of the strategy in the department of Escuintla, laying the groundwork for its progressive scale-up.
PAHO made a decisive contribution to strengthening community health governance by supporting the establishment and strengthening of community health committees, which were incorporated into local plans for the reduction of maternal mortality. In coordination with the Ministry of Public Health and Social Assistance and municipal authorities, technical cooperation promoted effective articulation between maternal health services and communities, including the integration of local leadership, traditional midwives, and other social actors through an intercultural and human rights–based approach.
Guatemala made considerable progress in implementing a comprehensive model for noncommunicable disease (NCD) and mental health care within PHC, with PAHO technical cooperation. During the biennium, support was provided for the implementation of the National Strategic Plan for Chronic Kidney Disease and for the development of standardized clinical pathways for hypertension, diabetes, and chronic kidney disease, strengthening comprehensive management across the PHC network.
During the 2024–2025 biennium, PAHO provided substantial support to bolster Guatemala’s progress toward the elimination of trachoma as a public health problem, through the strengthening of epidemiological surveillance, community action, and interprogrammatic integration. With support from Canada, the country implemented prevalence surveys among children aged 1–9 years in the communities of Quetzal (San Marcos) and Guineales (Sololá), covering 60 clusters and documenting a prevalence of 0.3%, well below the internationally accepted 5% threshold to define elimination. These results provide robust evidence of the progress achieved and strengthen national capacity to document and sustain elimination gains.
PAHO supported Guatemala in strengthening its preparedness and response to health emergencies through the formulation and approval of the Multihazard Institutional Response Plan of the Ministry of Public Health and Social Assistance, as well as the development of sectoral protocols for priority threats. Technical cooperation included support for multi hazard planning, the standardization of protocols for epidemiological and climate related events, and the organization of an interinstitutional simulation exercise (CENTAM GUARDIAN), which enabled the validation of operational capacities and improved coordination among stakeholders. Progress was made in the implementation of emergency medical teams and in aligning these actions with the International Health Regulations and the National Health Security Plan.
| Outcome Indicator | Baseline/Target | Rating |
|---|---|---|
| 01.b. Number of countries and territories that have implemented strategies to strengthen the response capacity of the first level of care | Target 2025 | Partially achieved |
| 07.b. Number of countries that have an interprofessional health team at the first level of care, consistent with their model of care | Baseline 2019 | Partially achieved |
| 09.a. Number of countries and territories that have achieved, by 2025, a reduction of at least 10 percentage points in the population reporting access barriers to health services, as compared to 2020 | Target 2025 | Not achieved |
| 09.b. Number of countries and territories that have reached at least 60% of their capacity to implement the essential public health functions | Target 2025 | Not achieved |
| Outcome Indicator | Baseline/Target | Rating |
|---|---|---|
| 05.c. Number of countries and territories with cervical cancer screening programs that achieve at least 70% coverage of screening in women aged 30-49 years, or for the age group defined by the national policy | Target 2025 | Not achieved |
| 05.e. Number of countries and territories whose surveillance systems have the capacity to report on key indicators of the Global Monitoring Framework for Noncommunicable Diseases | Baseline 2019 | Achieved |
| 05.g. Number of countries and territories that have increased capacity to manage mental health disorders at the first level of care | Target 2025 | Partially achieved |
| 05.h. Number of countries and territories that have increased the rate of persons admitted with mental disorders to general hospitals | Target 2025 | Not achieved |
| 06.b. Number of countries and territories that provide comprehensive post-rape care services in emergency health services, consistent with WHO guidelines | Target 2025 | Partially achieved |
| 13.d. Number of countries and territories that have eliminated industrially produced trans fatty acids | Target 2025 | Partially achieved |
| 15.a. Number of countries and territories with an operational advisory committee or lead agency on road safety that supports the development and/or implementation of a national road safety strategy | Baseline 2019 | Achieved |
| 15.b. Number of countries and territories that have a national or multisectoral plan addressing violence that includes the health system | Baseline 2019 | Achieved |
| Outcome Indicator | Baseline/Target | Rating |
|---|---|---|
| 12.a. Number of countries and territories reporting data on discrimination in health services experienced by men who have sex with men (MSM) in the past 12 months | Baseline 2019 | Partially achieved |
| 12.b. Number of countries and territories where the entire endemic (by vector transmission) territory or territorial unit has a domestic infestation index (by the main triatomine vector species or by the substitute vector, as the case may be) of less than or equal to 1% | Baseline 2019 | Achieved |
| 12.c. Number of countries and territories with increased antimicrobial resistance (AMR) surveillance capacity to guide the public health interventions for decreasing the risk and preventing the spread of multidrug-resistant infections through intersectoral action | Baseline 2019 | Partially achieved |
| 12.d. Number of countries and territories that have adequate mechanisms in place to prevent or mitigate risks to food safety | Target 2025 | Achieved |
| 17.a. Number of countries and territories that achieve 90% of viral suppression (viral load <1,000 copies/ml) in persons on antiretroviral therapy (ART) | Baseline 2019 | Partially achieved |
| 17.b. Number of countries and territories with >80% of malaria cases investigated and classified in areas targeted for elimination or prevention of reestablishment | Target 2025 | Achieved |
| 17.c [a]. Interruption of transmission of neglected infectious diseases (NID) in countries, following WHO criteria and guidelines [Trachoma] | Target 2025 | Partially achieved |
| 17.c [b]. Interruption of transmission of neglected infectious diseases (NID) in countries, following WHO criteria and guidelines [Chagas Disease] | Baseline 2019 | Achieved |
| 17.c [c]. Interruption of transmission of neglected infectious diseases (NID) in countries, following WHO criteria and guidelines [Dog-mediated human rabies] | Baseline 2019 | Partially achieved |
| 17.c [d]. Interruption of transmission of neglected infectious diseases (NID) in countries, following WHO criteria and guidelines [Human taeniasis/cysticercosis] | Target 2025 | Not achieved |
| 17.c [f]. Interruption of transmission of neglected infectious diseases (NID) in countries, following WHO criteria and guidelines [Onchocerciasis] | Baseline 2019 | Achieved |
| 17.d. Number of countries and territories with established capacity and effective processes to eliminate human rabies transmitted by dogs | Baseline 2019 | Achieved |
| Outcome Indicator | Baseline/Target | Rating |
|---|---|---|
| 18.g. Number of countries and territories with capacity to address health in chemical safety (including human health exposure to metals and/or pesticides) | Target 2025 | Achieved |
| 18.h. Number of countries and territories with capacity to address the health-related effects of climate change | Target 2025 | Achieved |
| Outcome Indicator | Baseline/Target | Rating |
|---|---|---|
| 20.a. Number of countries and territories that implement integrated interoperable information systems for health that include subnational disaggregation | Target 2025 | Discrepancy |
| 21.a. Number of countries and territories with functional governance for generating and using evidence integrated into health systems | Target 2025 | Discrepancy |
| 21.b. Number of countries and territories that generate, analyze, and use data and information according to health priorities, disaggregated by geopolitical and demographic strata, as appropriate to the national context | Target 2025 | Achieved |
| 21.c. Number of countries and territories with established mechanisms on knowledge management, multilingualism, open access, and publishing | Baseline 2019 | Achieved |
| 22.a. Number of countries and territories implementing a funded policy, strategy and/or agenda on research and innovation for health | Baseline 2019 | Achieved |
| 22.b. Number of countries and territories that have ethical standards for conducting research with human subjects | Target 2025 | Partially achieved |
| Outcome Indicator | Baseline/Target | Rating |
|---|---|---|
| 23.a. Number of countries and territories that meet or exceed minimum capacities to manage public health risks associated with emergencies | Baseline 2019 | Achieved |
| 23.b. Number of States Parties meeting and sustaining International Health Regulations (IHR) requirements for core capacities | Target 2025 | Achieved |
| 24.a. Number of countries and territories with installed capacity to effectively respond to major epidemics and pandemics | Target 2025 | Achieved |
| Outcome Indicator | Baseline/Target | Rating |
|---|---|---|
| 27.a. Proportion of countries and territories where the national health authority reports satisfaction with PAHO/WHO’s leading role on global and regional health issues | Target 2025 | Achieved |
| 27.b. Number of countries and territories for which there is alignment between the national health policy, strategy, or plan and the outcomes defined in the PAHO Strategic Plan 2020-2025 | Target 2025 | Achieved |
1. Access to comprehensive and quality health services
5. Access to services for NCDs and mental health conditions
6. Response capacity for violence and injuries
7. Health workforce
9. Strengthened stewardship and governance
12. Risk factors for communicable diseases
13. Risk factors for noncommunicable diseases
15. Intersectoral response to violence and injuries
17. Elimination of communicable diseases
18. Social and environmental determinants
20. Integrated information systems for health
21. Data, information, knowledge, and evidence
22. Research, ethics, and innovation for health
23. Health emergencies preparedness and risk reduction
24. Epidemic and pandemic prevention and control
27. Leadership and governance
| Output (OPT) Indicator | Baseline/Target | Rating |
|---|---|---|
| 01.1.a. Number of countries and territories with frameworks in place for integrated health service delivery networks (IHSDN) to improve the resolution capacity of the first level of care and integrate priority programs, including NCDs and the elimination agenda | Target 2025 | Partially achieved |
| 01.2.a. Number of countries and territories implementing strategies and/or plans of action to improve quality of care in health service delivery | Target 2025 | Partially achieved |
| 02.2.a. Number of countries and territories that measure percentage of women of reproductive age who have their need for family planning satisfied with modern methods, disaggregated by age, race/ethnicity, place of residence, and income level | Target 2025 | Achieved |
| 02.2.b. Number of countries and territories that measure percentage of pregnant women who received antenatal care four or more times, disaggregated by age, race/ethnicity, and place of residence | Target 2025 | Achieved |
| 02.2.c. Number of countries and territories implementing regular maternal and perinatal death reviews and audits | Target 2025 | Partially achieved |
| 02.2.d. Number of countries and territories that conduct periodic developmental assessment as part of their services for children | Target 2025 | Achieved |
| 02.2.e. Number of countries and territories implementing strategies to increase access to responsive and quality health services for adolescents | Baseline 2023 | Achieved |
| 02.2.g. Number of countries and territories that have set equity-based targets for access and coverage in at least one population living in conditions of vulnerability | Target 2025 | Discrepancy |
| 07.1.a. Number of countries and territories that are implementing a national policy on human resources for health | Target 2025 | Not achieved |
| 07.3.a. Number of countries and territories enabled to strengthen health workforce competencies and capacity-building programs through the Virtual Campus for Public Health and other WHO platforms | Target 2025 | Achieved |
| 08.1.b. Number of countries and territories with policies and/or strategies on research and development, innovation, and/or manufacturing to promote access to affordable health products | Target 2025 | Not achieved |
| 08.2.a. Number of countries and territories that have established an institutional development plan to improve regulatory capacity for health products based on the assessment of their national regulatory capacities by the Global Benchmarking Tool | Target 2025 | Achieved |
| 08.5.a. Number of countries and territories implementing plans to manage and oversee the essential medicines supply chain, including planning, forecasting, and availability | Target 2025 | Achieved |
| 10.1.a. Number of countries and territories implementing equitable health financing strategies and reforms to sustain progress toward universal health, including specific strategies to progressively increase public expenditure in health in a sustainable manner | Target 2025 | Partially achieved |
| Output (OPT) Indicator | Baseline/Target | Rating |
|---|---|---|
| 04.1.a. Number of countries and territories implementing national norms, standards, and tools aligned with PAHO and WHO guidelines on TB, HIV, STIs, and VH, with emphasis on key and vulnerable populations | Target 2025 | Achieved |
| 04.2.a. Number of countries and territories implementing the new arboviral disease guidelines for patient care in the Region of the Americas | Baseline 2023 | Achieved |
| 04.3.a. Number of NID-endemic countries and territories that implement PAHO recommendations on integrated interventions to reduce the burden of NIDs through their health systems | Target 2025 | Partially achieved |
| 04.4.a. Number of countries and territories that implement PAHO/WHO recommended policies and inter programmatic approaches related to malaria | Baseline 2023 | Achieved |
| 04.5.a. Number of countries and territories with DPT3 immunization coverage of at least 95% that are implementing strategies to reach unvaccinated and under-vaccinated populations | Target 2025 | Not achieved |
| 12.1.a. Number of countries and territories that have campaigns on antimicrobial resistance and rational use aimed at the general public and at professional sectors | Target 2025 | Achieved |
| 12.2.a. Number of countries and territories with active programs to control antimicrobial resistance through scaling up of infection prevention and control and provision of water, sanitation, and hygiene in health facilities | Target 2025 | Partially achieved |
| 12.3.a. Number of countries and territories with an established multisectoral coordinating mechanism to oversee national strategies to combat antimicrobial resistance | Target 2025 | Achieved |
| 12.4.a. Number of countries and territories that annually provide laboratory-based data on antimicrobial resistance | Baseline 2023 | Partially achieved |
| 12.5.a. Number of countries and territories reporting participation of communities in the response to HIV, TB, STIs, and viral hepatitis | Target 2025 | Achieved |
| 12.7.a. Number of countries and territories that have in place or under implementation intersectoral mandatory risk-based regulatory mechanisms, food monitoring and foodborne disease surveillance systems, or any other practice to protect public health from foodborne diseases, with a One Health approach | Baseline 2023 | Partially achieved |
| 12.8.a. Number of countries and territories that have programs to prevent or mitigate zoonotic diseases and snake/arthropod envenoming | Target 2025 | Partially achieved |
| 12.9.a. Number of countries and territories with integrated territorial actions for prevention, control, and/or surveillance of vector-borne transmission of Trypanosoma cruzi | Baseline 2023 | Partially achieved |
| 17.3.a. Number of countries and territories that administer hepatitis B vaccine to newborns during the first 24 hours | Baseline 2023 | Achieved |
| 17.5.a. Number of countries and territories that have maintained their status as free from both wild poliovirus and circulating vaccine-derived poliovirus | Target 2025 | Achieved |
| 17.8.a. Number of countries and territories implementing plans of action to strengthen prevention, prophylaxis, surveillance, and control for the validation of the elimination of rabies transmitted by dogs | Target 2025 | Achieved |
| Output (OPT) Indicator | Baseline/Target | Rating |
|---|---|---|
| 05.1.a. Number of countries and territories that are implementing evidence-based national guidelines/protocols/standards for the management of NCDs (i.e. cardiovascular disease, cancer, diabetes, and chronic respiratory disease) | Target 2025 | Achieved |
| 05.2.b. Number of countries and territories with implementation plans for population-based surveys developed with direct support from PASB | Target 2025 | Achieved |
| 05.5.a. Number of countries and territories that have defined a priority list of assistive devices and products | Target 2025 | Not achieved |
| 13.1.a. Number of countries and territories implementing population-based policy measures to reduce the harmful use of alcohol in line with PAHO and WHO resolutions | Target 2025 | Achieved |
| 13.1.b. Number of countries and territories implementing a national policy or strategy on physical activity | Target 2025 | Achieved |
| 13.1.f. Number of Member States that have implemented the four major demand-reduction measures in the WHO Framework Convention on Tobacco Control (FCTC) at the highest level of achievement | Target 2025 | Partially achieved |
| 16.1.a. Number of countries and territories implementing policies and legislative frameworks to promote and improve mental health in line with global human rights instruments | Target 2025 | Achieved |
| Output (OPT) Indicator | Baseline/Target | Rating |
|---|---|---|
| 18.2.a. Number of countries and territories implementing water and sanitation safety plans, policies, programs, and/or interventions to reduce health risks associated with water quality and unsanitary conditions, following WHO guidelines | Target 2025 | Achieved |
| 18.2.b. Number of countries implementing plans, policies, programs, and/or interventions to increase climate resilience and environmental sustainability of health care waste management practices, following WHO Guidelines | Target 2025 | Achieved |
| 18.2.d. Number of countries and territories implementing plans, policies, programs, and/or interventions to reduce health risks associated with hazardous chemical exposures, following the WHO Chemicals Road Map, the Minamata Convention, and other chemical-related policies and programs | Target 2025 | Achieved |
| 18.2.f. Number of countries and territories implementing plans, policies, programs, and/or interventions to reduce health risks associated with household air pollution due to use of solid fuels for cooking and heating, following WHO guidelines | Target 2025 | Partially achieved |
| 19.1.a. Number of countries and territories that have laws, regulations, or policies in at least two categories of healthy settings | Target 2025 | Achieved |
| 19.4.b. Number of countries and territories implementing mechanisms that facilitate the participation of community organizations and leaders in public health programs | Target 2025 | Achieved |
| 26.2.a. Number of countries and territories implementing policies, plans, and strategies to advance health equity | Target 2025 | Achieved |
| 26.3.a. Number of countries and territories implementing policies, plans, and programs to advance gender equality in health | Target 2025 | Achieved |
| 26.4.a. Number of countries and territories implementing policies, plans, and programs to advance ethnic equality in health | Baseline 2023 | Achieved |
| 26.5.a. Number of countries and territories using human rights norms and standards in the formulation and implementation of health-related policies, plans, programs, and legislation | Baseline 2023 | Achieved |
| Output (OPT) Indicator | Baseline/Target | Rating |
|---|---|---|
| 20.1.a. Number of countries and territories that have developed and implemented a plan to strengthen information systems for health based on PAHO’s IS4H maturity assessment model | Baseline 2023 | Achieved |
| 20.2.a. Number of countries and territories implementing an updated plan of action for strengthening the quality and coverage of vital statistics | Target 2025 | Not achieved |
| 21.3.a. Number of countries and territories that generate and disseminate health analyses and/or health intelligence reports on relevant public health topics, including SDG 3 progress monitoring and health equity analyses | Target 2025 | Achieved |
| 22.2.a. Number of countries and territories with the national health authority enabled to address ethical issues and establish effective mechanisms for ethics oversight of research | Baseline 2023 | Achieved |
| Output (OPT) Indicator | Baseline/Target | Rating |
|---|---|---|
| 23.1.a. Number of States Parties completing annual reporting on the International Health Regulations (2005) | Baseline 2023 | Achieved |
| 23.1.b. Number of countries and territories that have evaluated disaster and emergency preparedness capacities in the health sector | Baseline 2023 | Achieved |
| 23.2.a. Number of States Parties with national action plans developed for strengthening International Health Regulations (2005) core capacities | Target 2025 | Not achieved |
| 23.2.b. Number of countries and territories with full-time staff assigned to health emergencies | Baseline 2023 | Achieved |
| 23.3.a. Number of States Parties that have conducted simulation exercises or after-action review | Target 2025 | Not achieved |
| 23.4.a. Number of countries and territories that include safe hospital criteria in the planning, design, construction, and operation of health services | Target 2025 | Discrepancy |
| 24.2.a. Number of countries and territories with strategies and/or plans in place to detect and respond to high-threat and emerging pathogens, including emerging zoonotic pathogens | Baseline 2023 | Achieved |
| 24.3.b. Number of countries and territories performing regular monitoring/auditing of infection prevention and control practices in referral care facilities | Target 2025 | Not achieved |
| 24.3.c. Number of countries and territories with operational integrated surveillance systems and pandemic preparedness plans for respiratory viruses, including influenza and COVID-19 | Baseline 2023 | Achieved |